Abstract
To assess whether bacteriological surveillance cultures can be used to predict infection in neutropenic patients, cultures were performed during the period of neutropenia of nose, throat and urine specimens collected once weekly and faeces specimens collected twice weekly. Seventy-six consecutively observed patients undergoing chemotherapy for haematological or non-haematological diseases were investigated. Severe infection including septicaemia, lower respiratory tract infection, anorectal lesion and urinary tract infection occurred in 32 patients.Enterobacter cloacae, Escherichia coli andPseudomonas aeruginosa were the organisms most commonly involved. In the majority of cases of septicaemia the organisms were isolated from the faeces, often in pure culture, prior to the onset of septicaemia. Most of the isolates ofEnterobacter cloacae were resistant to the empiric antibiotic therapy used in the unit and were able to colonise multiple sites, presumably increasing the risk of subsequent infection. Faecal culture is the most useful approach in bacteriological surveillance in neutropenic patients.
Similar content being viewed by others
References
Bodey, G. P., Buckley, M., Sathe, Y. S., Freireich, E. J. Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Annals of Internal Medicine 1966, 64: 328–340.
Marcus, E. G., Goldman, J. M. Management of infection in neutropenic patient. British Medical Journal 1986, 293: 406–408.
Buckner, C. D., Clift, R. A., Sanders, J. E., Meyer, J. D., Counts, G. W., Farewell, V. T., Thomas, E. D. andthe Seattle Marrow Transplant Team Protective environment for marrow transplant recipients — a prospective study. Annals of Internal Medicine 1978, 89: 893–901.
De Vries-Hosper, H. G., Sleijfer, D. T., Mulder, N. H., van der Waaj, D., Nieweg, H. O., van Saene, H. K. F. Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients. Antimicrobial Agents and Chemotherapy 1981, 19: 813–820.
Cohen, M. I., Murphy, M. T., Counts, G. W., Buckner, C. D., Clift, R. A., Meyers, J. D. Prediction by surveillance cultures of bacteremia among neutropenic patients treated in a protective environment. Journal of Infectious Diseases 1983, 147: 789–793.
Schimpff, S. C. Surveillance cultures. Journal of Infectious Diseases 1981, 144: 81–84.
Galen, R. S., Gambino, S. R. Beyond normality: the predictive value and efficiency of medical diagnosis. John Wiley, New York, 1975, p. 29–40.
Stokes, E. J., Ridgway, G. L. Clinical bacteriology. Edward Arnold, London, 1980, p. 219–220.
Pitt, T. L. State of the art: typingPseudomonas aeruginosa. Journal of Hospital Infection 1980, 1: 193–199.
Gaston, M. A., Bucher, C., Pitt, T. L. O serotyping scheme forEnterobacter cloacae. Journal of Clinical Microbiology 1983, 18: 1079–1083.
Gaston, M. A. Isolation and selection of bacteriophage typing set ofEnterobacter cloacae. Journal of Medical Microbiology 1987, 24: 285–290.
Schimpff, S. C., Young, V. M., Greene, W. H., Vermeulen, G. D., Moody, M. R., Wiernik, P. H. Origin of infection in acute non-lymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Annals of Internal Medicine 1972, 77: 707–714.
Newman, K. A., Schimpff, S. C., Young, V. M., Wiernik, P. H. Lessons learned from surveillance cultures in patients with acute non-lymphocytic leukemia — usefulness for epidemiologic prevention and therapeutic research. American Journal of Medicine 1981, 70: 423–431.
Schimpff, S. C., Greene, W. H., Young, V. M., Wiernik, P. H. Significance ofPseudomonas aeruginosa in patient with leukemia or lymphoma. Journal of Infectious Diseases 1974, Supplement 130: 24–31.
John, J. F., Sharbaugh, R. J., Bannister, E. R. Enterobacter cloacae, bacteremia, epidemiology and antibiotic resistance. Reviews of Infectious Diseases 1982, 4: 13–28.
Markowitz, S. M., Smith, S. M., Williams, D. S. Retrospective analysis of plasmid patterns in a study of burn unit outbreaks of infection due toEnterobacter cloacae. Journal of Infectious Diseases 1983, 148: 18–23.
Griffin, H. G., Foster, T. J., Falkiner, F. R., Carr, M. E., Coleman, D. C. Molecular analysis of multiple-resistance plasmids transferred from gram-negative bacteria isolated in a urological unit. Antimicrobial Agents and Chemotherapy 1985, 28: 413–418.
Gurwith, M. J., Brunton, J. L., Lank, B. A., Ronald, A. R., Harding, G. K. M. Granulocytopenia in hospitalised patients. American Journal of Medicine 1978, 64: 121–132.
Kramer, B. S., Pizzo, P. A., Robichaud, K. J., Witesbsky, F., Wesly, R. Role of serial microbiologic surveillance and clinical evaluation in the management of cancer patients with fever and granulocytopenia. American Journal of Medicine 1982, 72: 561–568.
Collignon, P., Munro, R. Management of infection in neutropenic patients. British Medical Journal 1986, 293: 817.
Milligan, D. W., Taylor, M. Management of infection in neutropenic patients. British Medical Journal 1986, 293: 817.
Wells, C. L., Ferrieri, P., Weisdorf, D. J., Rhame, F. S. The importance of surveillance stool cultures during periods of severe neutropenia. Infection Control 1987, 8: 317–319.
Meyer, D. V., Winston, D., Young, L. S., Gale, R. P., Martin, W. J. Surveillance cultures in immunosuppressed patients: What do they mean? In: Nelson, J. D., Grassi, C. (ed.): Current chemotherapy and infectious diseases. American Society for Microbiology, Washington, DC, 1980, p. 1436–1437.
Dejace, P., Klastersky, J. Emergence of resistance as a consequence of antimicrobial prophylaxis in immunocompromised patients. Scandinavian Journal of Infectious Diseases 1986, Supplement 49: 165–171.
Wingard, J. R., Dick, J., Charache, P., Saral, R. Antibiotic resistant bacteria in surveillance stool cultures of patients with prolonged neutropenia. Antimicrobial Agents and Chemotherapy 1986, 30: 435–439.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Daw, M.A., Munnelly, P., McCann, S.R. et al. Value of surveillance cultures in the management of neutropenic patients. Eur. J. Clin. Microbiol. Infect. Dis. 7, 742–747 (1988). https://doi.org/10.1007/BF01975040
Issue Date:
DOI: https://doi.org/10.1007/BF01975040